A CE-marked (IVDR Class C) and UKCA-cleared in vitro LPS-induced TNFα Release Assay (TARA) that detects bacteremia-associated immunosuppression and sepsis by assessing innate immune responsiveness in whole blood. The test can detect immunosuppression as early as one hour after infection, enabling ti...
Manufactured by
Barcelona, Spain
Loop Diagnostics S.L. (Loop Dx): Revolutionizing Rapid Infection Diagnostics Loop Diagnostics is a Spanish-based IVD company that developed SeptiLoop, the first CE-IVDR Class C near-patient test that helps identify early immunosuppression induced by bacteremia, including sepsis. SeptiLoop also holds UKCA certification. Our uniqueness is the functional host-response approach. Instead of static serum markers, we stimulate whole blood ex vivo with LPS and quantify the patient s TNF-α release. This response assay detects immune dysfunction from first contact in the ED and through the first 72 hours of infection, with a simple workflow and a result in under 3 hours. Clinical studies in emergency settings showed 91 percent sensitivity and 80 percent specificity, with performance that compares favorably to conventional serum biomarkers for early detection. The technology has been evaluated in more than one thousand suspected sepsis patients across prospective feasibility and accuracy studies. Our near-term goal is to scale hospital adoption in Europe, embed SeptiLoop into ED and ICU pathways, and advance regulatory and market access in the UK, EU, and US. We are also extending the platform to new clinical uses using the same immune-response methodology. The challenge is accelerating the shift toward rapid functional testing that informs triage and early decision-making. Our vision is for dynamic immune assessment to become a standard pillar of acute infection management, reducing mortality, adverse effects, and unnecessary antibiotic use. Our Goals Accelerate Diagnosis : Reduce the time to diagnose bloodstream infections, enabling earlier intervention and improving patient outcomes. Enhance Precision : Increase the accuracy of infection detection to ensure patients receive the most effective treatments promptly. Improve Accessibility : Develop cost-effective diagnostic tools that can be easily integrated into clinical settings worldwide. Challenges We Tackle Sepsis Detection : Sepsis is a life-threatening condition that requires immediate attention. Our technology aims to identify sepsis at its earliest stages. Antimicrobial Resistance : By enabling precise diagnostics, we help reduce the misuse of antibiotics, combating the global issue of antibiotic resistance. Healthcare Efficiency : Providing rapid results can significantly reduce hospital stays and healthcare costs, optimizing resource allocation. Our Vision We envision a world where rapid and accurate diagnostics are accessible, leading to timely treatments and better healthcare outcomes. By bridging the gap between unmet clinical needs and innovative solutions, we strive to transform the landscape of medical diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
J R Biomedical Ltd
United Kingdom · 4 relevant products
Pilot Gene Technology (Hangzhou) Co., Ltd.
China · 5 relevant products
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 2 relevant products
Rayto Life and Analytical Sciences Co., Ltd.
China · 2 relevant products
Zybio Inc.
China · 1 relevant product
Diasorin
United States · 2 relevant products
Human Gesellschaft fuer Biochemica und Diagnostica mbH
Germany · 1 relevant product
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 2 relevant products
Cytovale
United States · 3 relevant products
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China · 4 relevant products
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 104 closest product alternatives
J R Biomedical Ltd · United Kingdom
An in vitro diagnostic immunochromatographic lateral-flow assay for the semi-quantitative measurement of human soluble Toll-like receptor 2 (sTLR2) in plasma, used as a biomarker for sepsis and other inflammatory conditions. The test delivers results in 10 minutes from a 20µL plasma or serum sample. Each kit contains 10 test devices and uses proprietary sTLR2 monoclonal antibodies. The assay is UKCA certified for clinical use in Great Britain and is developed and manufactured in the UK according to ISO13485 quality standards.
J R Biomedical Ltd · United Kingdom
Each kit contains 10 tests cassettes for the semi-quantitative measurement of soluble Toll-like receptor 2 (sTLR2) in blood. UKCA certified. Results in 10 minutes.
J R Biomedical Ltd · United Kingdom
An immunochromatographic lateral-flow assay for semi-quantitative measurement of soluble Toll-like receptor 2 in plasma or serum. The test provides results within 10 minutes and helps diagnose sepsis and inflammatory conditions. Each kit contains 10 test devices with proprietary monoclonal antibodies for sTLR2 detection.
Pilot Gene Technology (Hangzhou) Co., Ltd. · China
Serial testing assay for monitoring pathogen clearance and treatment response in sepsis patients. Quantifies bacterial or fungal loads during therapy.
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Exclusive patent-protected assay for simultaneous detection of procalcitonin, interleukin-6, and C-reactive protein. Provides comprehensive inflammatory biomarker assessment for sepsis and infection diagnostics.
Rayto Life and Analytical Sciences Co., Ltd. · China
Sensitive biomarker assay for bacterial infection detection and sepsis assessment. Guides antimicrobial therapy decision-making.
Zybio Inc. · China
Immunoassay for procalcitonin measurement in sepsis and infection diagnosis. Supports antibiotic stewardship decisions.
Diasorin · United States
Diagnostic test for faster and more accurate patient triage in infection assessment. Helps reduce unnecessary antibiotic use through improved clinical decision-making.
J R Biomedical Ltd · United Kingdom
An immunochromatographic assay for the semi-quantitative measurement of human soluble Toll-like receptor 2 (sTLR2) in serum. Each kit contains 10 foil pouches with test devices, sTLR2 diluent bottle, and materials sufficient to test 10 patient samples. The test requires a 20µL sample (plasma or serum) and delivers results in 10 minutes, with UKCA certification. The test works by binding sTLR2 in the sample to a gold nanoparticle-conjugated mouse anti-TLR2 monoclonal antibody, which then flows through a membrane where a second antibody captures the complex, with result intensity proportional to sTLR2 concentration and classified into four semi-quantitative classes (Class 0-3) based on pg/mL levels.
Human Gesellschaft fuer Biochemica und Diagnostica mbH · Germany
Biomarker test for sepsis risk assessment that detects elevation earlier than CRP and PCT markers. Enables earlier clinical intervention in sepsis management.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid diagnostic assays for CRP, PCT, and SAA that enable physicians to quickly perform differential diagnosis between bacterial and viral infections directly at the patient's bedside. Vital for antibiotic stewardship and sepsis management.
Cytovale · United States
An FDA-cleared in vitro diagnostic test for adult patients with signs and symptoms of infection who present to the Emergency Department. The IntelliSep test runs on the Cytovale medical device to risk-stratify patients based on their probability of having sepsis with organ dysfunction manifesting within the first 3 days after testing. It provides test results in around 8 minutes by analyzing the immune response to infection through the biomechanical properties of white blood cells, enabling faster care and optimized patient outcomes.
92 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products